Nanoparticle scaffold to boost meniscus healing
Activation of endogenous progenitors via a nanoparticle-conjugated fibrous system to enhance meniscus repair
A nanoparticle-linked fiber therapy aims to wake up the knee's own repair cells to help adults heal meniscus tears faster and protect cartilage.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11253305 on NIH RePORTER |
What this research studies
If you had a meniscus tear, researchers are developing a tiny-fiber scaffold coated with nanoparticles to deliver signals that activate the knee's own repair cells. They identified Gli1+ progenitor cells that can grow and make meniscus tissue and will use lab tests and mouse injury models to see if the scaffold plus a hedgehog (Hh) pathway activator improves healing. The team will measure tissue repair, cell growth, and whether treated knees avoid cartilage damage that leads to osteoarthritis. Successful animal results would guide steps toward treatments that could be tested in people with meniscus injuries.
Who could benefit from this research
Good fit: Adults (21+) with recent meniscus tears who are interested in biological repair approaches would be the likely candidates for future trials.
Not a fit: People without meniscal injuries, those with advanced end-stage osteoarthritis where repair is unlikely, or those unable to receive intra-articular treatments may not benefit.
Why it matters
Potential benefit: Could help meniscus tears heal better, restore knee function, and reduce the risk of later osteoarthritis.
How similar studies have performed: Previous mouse work activating the Hedgehog/Gli1 pathway sped meniscus repair, but delivering that signal via a nanoparticle-fiber system is a new translational approach with limited prior human testing.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Qin, Ling — University of Pennsylvania
- Study coordinator: Qin, Ling
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.